Adjuvant axitinib dose modification in renal cell carcinoma (RCC): Analysis of the ATLAS study

Category Primary study
JournalJournal of Clinical Oncology
Year 2019
This article has no abstract
Epistemonikos ID: cbcf5d20b365fc1f061c7880ec43b42b78001a5b
First added on: Feb 11, 2025